Intellectual Property
Minneapolis/St. Paul
Schwegman Lundberg & Woessner & Post Grant Trial Practice
"Whats" - Audit Action Sheet
Value Management and Cash Flow
Advantages of Registering a Trademark
Practicing an Invention
Implementing a Value-Driven Portfolio Process
Biologics vs Small Molecules
Attributes of a Good Patent
How Does the Knowledge Gap Worsen Over Time?
Technical Background
Claim Abstraction Theory
Steps to Obtaining a Patent
Third Party Confidentiality
Moderate Risk Joint Ventures
The Advantage of Filing First
Considerations Before Hiring IP Council
Assessing Executive Experience
Cost/Value Curve of Patent a Portfolio
Freedom to Operate
Patent Strategy Considerations
Inventorship
Downside of Static Budget Allocation for Patents
Importance of Freedom To Operate
Naming Problems with BioSimilars
Evaluation Agreement and Computer Codes
Scope Concepts and Headnotes
Raising Good Prosecution Visibility
Tracking Work History
Low Risk Joint Ventures
Broad Patent Claim
Inter Partes Review
Joint Venture Pitfalls
Requirements to Receive a Patent
How is the Entire Patent Considered Prior Art?
Approvals of BioSimilars in Europe
Types of Intellectual Property Protection
Risks of OSS
Trade Name Protection and Trademark Protection
Types of Inventions That Are Patentable
The Different Types of Marks
5 Year View Point
Inventors and Patent Analytics
Freedom To Operate vs Clearance
Biologics Price Competition and Innovation Act
Two Main Value Drivers
Open Source Software
How is Schwegman Lundberg & Woessner Different?
Intellectual Property Protection
"TM" Symbol
Importance of Post-Grant Proceedings
"How Much" - Audit Action Sheet
Trade Names vs Trademarks
Equal Value Patents
Background
Goal of a Value-Driven Patent Portfolio
"Who" - Audit Action Sheet
"SM" Symbol
Non-Disclosure Agreement
What is a BioSimilar Product Under US Law?
Experience
Impact of Post-Grant Proceedings
Litigation Density
Who Determines Substitution Factors?
Unlicensed Source Codes
Joint Venture and Financial Agreements
Becoming a Patent Lawyer
Challenges When Dealing with Patent Matters
Prior Art in Prosecution vs Prior Art in Litigation
What is a Patent Portfolio?
Trademark
Post-Grant Options and Estoppel
The Five Components of an Open Source Software Policy
Consequences of a Poorly Drafted Patent
Using Product Association with IP Assets
Hiring Patent Council
What Doesn't a Patent Provide?
Provisional vs Non-Provisional Patent
Circle "R"
Hard Assets
Proper Way to Use a Trademark
Are BioSimilars Being Approved in the US?
What Does an Audit Action Sheet Look Like?
Provisional Patent
What is a Patent?
Common Law Trademark Rights
What Engineers Can Learn from Patent Profile Analytics
Meet David Black
Rewards of the Practice
Demonstrating BioSimilarity Under U.S. Law
First Step in Performing a Patent Portfolio Audit
Process for Registering a Trademark in the United States
How Big Should My First Patent Be?
Portfolio Mapping
Patent Profile Analytics and Managers
Picking a Trademark
Convergence Density
Prior Art Challenge
Why Perform Risk Profile?
Value Management Lifecycle
Renewing a Trademark Registration
Segmenting a Portfolio
What Should a Company Understand at the End of an IP Audit?
Independent Claim vs Dependent Claim
Impact of PTAB
Establishing Confidentiality
How Do Patent Portfolio Values Become Concentrated over Time?
Tools for Auditing a Patent Portfolio
Forward Citation Landscape
Attorneys Not Understanding the Market
Trade Secrets
Patent Portfolio and Budgets/Spending
Contractual Intellectual Property Rights
Patent Profile Analytics and Engineers
Sponsor
Standard for Getting a Patent
Preventing "Genericide"
Trade Dress
How to Fix the Knowledge Gap
Secondary Meaning of a Trademark
NDAs and Customers
How Long Does an FTO Take?
"Claims" of a Patent
By the Numbers Overview
Infringing on Another Patent
How to Remedy Unwanted Disclosure of Confidential Information
Factors That Make a Patent Valuable
Patents 101
Patents and Practicing an Invention
Trademark Filing Considerations
What is a Trademark?
Post-Grant Options and Cost
Freedom to Operate (FTO) Process
OSS Licensing Conditions
Cost of Registering a Trademark
A Better Way to Allocate Patent Application Budgets
Picking a Domain Name
Seeking Money from Investors
Value Management and Risk Management
Reasons to Consider Joint Ventures
Office Action
Specimen
What to Do When First Selecting a Mark
How is Open Source Incorporated into Software?
Open Source Initiative
What Makes Schwegman, Lundberg & Woessner Different?
Discovering Annuity Information
Forms of Confidential Information
Engineers Not Understanding Patents
How Should IP be Considered for Acquisition?
"Whens" - Audit Action Sheet
Risks of Not Patenting
Repeating Competitor Audits
Factors That Cause a Patent to Decline in Value
Unanticipated OSS
ITU
Helping In-House Council
NDAs and Computer Codes
Calculating New Investments
"Wheres" - Audit Action Sheet
Improperly Marked Product
Limiting Issues Defined in District Court
Claim Maps and BioSimilars
Signing an NDA
Limited Valuable Patents in Technology Area
Merrifield Synthesis
Patents and Other Forms of Intellectual Property Protection
What is an Invention?
Post-Grant Review
Prior Art and Rejections
Cost/Value Curve of a High Level Patent
Consequences of Disclosing Confidential Information
Am I Required to Search for Prior Art?
Why Do You Enjoy Being a Lawyer?
Geographic Insight and Patent Profile Analytics
What IP Should I Spend Money on First?
Outside of Law
Ideal Patent Strategy
Benefits of Audit Action Sheet
Mitigating Risks of Past Damages
Why Is Executing an NDA Not Enough?
Refused Trademark Recourse
Backward Citations
Auction Audit Sheet - Key Issues to Address
Different Parts of a Patent Document
Covered Business Method Review
What is Prior Art?
Patent Status Updates
Soft Assets
Meet Mark Stignani
Post-Litigation Challenges
Interpretational Differences Between Prosecution and Litigation
The Case of the Joint Marketing Agreement Gone Bad
Golden Rule of Auditing a Patent Portfolio
How Much Does it Cost to Get a Patent?
Patent Ownership and Patent Profile Analytics
Genericide
Pre-Litigation Challenges
Schwegman, Lundberg & Woessner - Chemicals and Pharmaceuticals
What Should a Company Patent?
How to Navigate BioSimilar Challenges
What Do I Give up in Getting My Patent?
How can OSS Negatively Affect a Company?
Merely Descriptive Refusal
Risk Profile
Improving Patent Portfolio Value
Traditional Re-Examination
Get Your Assignments Straight - Contribution of Owners
PTAB Final Argument Trial Dynamics
How do Patent Prosecution Services Vary in Value?
Trademarks and Brand Value
Patent Infringement
What is a BioSimilar?
Infringement on the Rights of Other Patents
Patent Profile Analytics and Researchers
Post-Grant Options and Grounds of Challenge
Patent Citation Ranking
PTAB Timing Trial Dynamics
Joint Venture Ground Rules
Common Reasons Trademarks Are Rejected
Impact of US Hatch Waxman Act 1984
Most Common Client Question
Importance of Getting a Patent
Attorneys and Patent Profile Analytics
Patent Owner Rights
Determining Likelihood of Confusion
Why Should Claims Not Be Read on the Prior Art?
FDA Guidelines for Demonstrating Biosimilarity
Licensing Density
Marking a Product
Is There Still a Place for Traditional Re-Examination?
When is a House like a Patent?
Managing OSS
BioSimilar Patenting Litigation Involving Large Amounts of Money
Do Narrow Patents Add Value to a Portfolio?
Is A United States Registered Trademark Effective in Other Countries?
Audit Action Sheet
Post-Grant Proceedings and Patent Enforcement
How Does the Knowledge Gap Develop?
Should IP be Part of Our Business Plan?
When to Do a Freedom to Operate
Patent Trial and Appeal Board
Effective Stay Strategy
Post-Grant Proceedings
Categories of Marks
Patent Analytics and Competition
How is Open Source Software Enforced?
Date of First Use
Important Attributes to Being a Successful Patent Lawyer
High Risk Joint Ventures
Intent of Patent Laws
A Less Expensive Alternative
4 Ways to Prepare your Patent Portfolio for Battle.
IP Registration Density
Rebutting a Merely Descriptive Refusal
Portfolio Dashboard - Inventor Information
Purposes of a Trademark
Joint Ventures and Dispute Resolution
Qualifying for a Patent
How Should IP be Considered for Growth?
First Item on IP To-Do List
Researching Competitors' IP
Confidential Information and Business Damage
Copyright
Budgeting for Drafting and Prosecution
Wasting Money on Low-Value Patents
Patent Examination Process
Litigation and BioSimilar Patenting
Domain Registration Considerations
Post-Grant Options
Value-Driven Patent Portfolio
Confidential Information
Why Are Biologicals so Important?
Freedom To Operate
Cited Art Landscape
Inventorship vs Ownership
